Purchases and Sales Made in Q4 2021 in Ngm Biopharmaceuticals Inc (NGM)
This table provides information about the institutional ownership of Ngm Biopharmaceuticals Inc (NGM) during Q4 2021. The information is specifically focused on institutions that hold shares of NGM BIOPHARMACEUTICALS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2022
Q4 2021
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-64.5K- 8.5% |
$1.11M - $1.42M
|
694K
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Euclidean Capital LLC
New York, NY |
SELL
|
- |
-85.6K- 10.29% |
$1.48M - $1.88M
|
747K
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-86KClosed |
$1.48M - $1.89M
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Blackstone Inc
New York, NY |
SELL
|
- |
-189KClosed |
$3.26M - $4.16M
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Octagon Capital Advisors LP
New York, NY |
SELL
|
- |
-200KClosed |
$3.45M - $4.4M
|
0
$0
|
|
|
Feb 10, 2022
Q4 2021
|
Citigroup Inc
|
SELL
|
- |
-221K- 92.75% |
$3.81M - $4.86M
|
17.2K
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-366K- 95.26% |
$6.33M - $8.07M
|
18.2K
$0
|
|
|
Feb 10, 2022
Q4 2021
|
Candriam S.C.A.
|
SELL
|
- |
-564KClosed |
$9.74M - $12.4M
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-1.92M- 76.74% |
$33.2M - $42.3M
|
583K
$0
|